CUSIP 00091F304COM NEWABVCQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
14 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vanguard Group Inc | 287.9K | $613.3K | +20.5K | Added |
| 2 | Geode Capital Management, LLC | 202.4K | $431.1K | +14.6K | Added |
| 3 | Renaissance Technologies LLC | 114.3K | $243.4K | +3.8K | Added |
| 4 | State Street Corp | 72.8K | $155.1K |
| Held |
| 5 | Blackrock, Inc. | 56.4K | $120.2K | 0 | Held |
| 6 | Citadel Advisors LLC | 55.5K | $118.3K | +39.9K | Added |
| 7 | Northern Trust Corp | 32.1K | $68.3K | +7.3K | Added |
| 8 | Xtx Topco Ltd | 11.3K | $24.0K | −13.5K | Reduced |
| 9 | Jane Street Group, LLC | 10.9K | $23.1K | +10.9K | New |
| 10 | Morgan Stanley | 5.2K | $11.0K | +5.2K | New |
See every fund holding Abvc Biopharma Inc, with full quarter-over-quarter share changes.
Unlock all holders